CDSCO (India)
NOTICE
Misleading or false claims of the product FatX solution registered under COS-2 vide RC no. RC/COS-003300 by the firm M/s Tekno Midas Aesthetics
Published: 10/28/2026Detected: 10/28/2026
Summary preview
Highlights enforcement attention on the FatX solution’s registration under COS-2 (RC/COS-003300) due to misleading or false product claims, which may trigger corrective actions for claim substantiation and marketing…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountsafety
labeling
manufacturing
quality
#misleading claims
#false advertising
#COS-2
#RC/COS-003300
#product registration
Official Source Document Source Verified
Access the original document directly from INDIA CDSCO.
More from CDSCO (India)
- Appointment of Central Compounding Authority Order10/28/2026
- Digital Monitoring System on the ONDLS portal for monitoring the supply chain of high-risk solvents.10/27/2026
- Strict compliance with the Drugs Rules, 1945, for testing of raw materials and finished formulations10/27/2026
- Misleading or false claims of the product FatX solution registered under COS-2 vide RC no. RC/COS-003300 by the firm M/s Tekno Midas Aesthetics10/26/2026
- WHO Alert on falsified DEFITELIO (Defibrotide) 80 mg/ml concentrate for solution for infusion, B. No. 24GC01A, Exp date 04/2027, Mfg by: Patheon, II Trav. sx Via Morolense, 5, 03013 Ferentino (FR) Italy and Marketing authorisation holder: Gentium S.r.l, Piazza XX Settembre, 2, 22079 Villa Guardia (Como) Italy and identified in India10/26/2026